Elastography in Predicting Renal Outcome
Application of Transthoracic Shear-wave Ultrasound Elastography in the Evaluation of Renal Function and Diagnosis of Renal Disease
1 other identifier
observational
500
1 country
1
Brief Summary
There are two types of elastography: strain elastography assesses the degree of strain when applying a given amount of force to the skin. Shear-wave elastography assesses the velocity of shear wave propagation within the target lesion. A part of the tissue is deformed by a "push pulse", the velocity of the shear waves propagating within the tissue is detected, and the stiffness of the tissue is assessed based on the detected shear velocity. Shear-wave elastography has been intensively studied in thyroid, breast, liver, cervical lymph nodes, and musculoskeletal diseases with promising result. Transthoracic shear-wave ultrasound is also used for the prediction of lung malignancy. In progressive renal disease, renal function decline correlates with the extent of interstitial fibrosis, irrespective of the original pathology. Experience and research in using shear-wave elastography to study the stiffness of renal parenchyma and renal fibrosis are scanty. The investigators will conduct a prospective observational study. This study aims to provide the information of tissue elasticity in different etiologies of renal diseases and to validate the predictive value of shear-wave elastography in predicting renal function and renal fibrosis. By assuming a power of 0.8, a two-side p value of 0.05, a ratio of 0.2 (sample sizes in negative/positive groups) to detect the difference between area under ROC curve and null hypothesis value (0.8 and 0.7), a target sample of 273 (with a 5% cushion, 260\~290) patients is required.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 27, 2021
CompletedFirst Submitted
Initial submission to the registry
December 28, 2021
CompletedFirst Posted
Study publicly available on registry
April 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 12, 2024
December 1, 2023
3 years
December 28, 2021
April 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
collect medical record of blood urea nitrogen and Creatinine
3 months and 12 months
Interventions
When routine renal ultrasound is arranged, patients will be invited to receive elastography at the same time.
Eligibility Criteria
patients receiving scheduled renal biopsy and scheduled renal sonography
You may qualify if:
- patients receiving scheduled renal biopsy and scheduled renal sonography
You may not qualify if:
- age \< 20 y/o, patients who can't hold their breath for at least 5 seconds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2021
First Posted
April 12, 2024
Study Start
December 27, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
April 12, 2024
Record last verified: 2023-12